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Abstract
Introduction: The pancreas is a well-documented but relatively uncommon site of non-small-cell
cancer metastases. However, at the time of diagnosis the disease is usually locoregionally advanced,
therefore therapeutic management is mostly palliative and symptomatic.
Case Presentation: We report the case of a 77-year-old Caucasian male patient who presented
initially with a clinical picture of acute cholangitis approximately 2 years after a left lower lobectomy
for a low-grade squamous lung carcinoma. CT scan imaging of the abdomen and chest revealed an
abnormal growth of the pancreatic head and distention of both the intra- and extra-hepatic billiary
tree, whereas osteolytic abnormalities were observed of the 5th left rib, consistent with secondary
deposits. Initially an endoscopic retrograde cholangio-pancreatography (ERCP) and
sphincterectomy was performed and a plastic stent was placed in the common bile duct to
decompress the biliary tree. Cytological examination of the aspirate collected by FNA of the
pancreatic lession under EUS guidance revealed cells consistent with a low grade squamous lung
carcinoma. Two months later an open cholecystectomy along with a gastrojejunostomy was
performed to relieve the patient's gastric outlet obstruction symptoms. Following remission of the
patient's attack of acute cholangitis and excessive vomiting he was released from the hospital and
instructed to initiate chemotherapy with vinorelbine. The patient succumbed to disseminated
disease almost 5 months later.
Conclusion: Symptomatic metastatic lesions of the pancreas from squamous cell carcinoma of the
lung are infrequent. Typically, the patients remain asymptomatic until their disease reaches a fairly
advanced stage and therapeutic options are limited to palliative measures. A high index of suspicion
is the only way of early detection and potentially effective treatment for this rare localization of
metastatic squamous lung carcinoma.
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Introduction
A variety of malignant tumors have been documented to
metastasize to the pancreas. The most common primary
site for pancreatic metastases is the lung (18-27%) [1,2].
However, this relatively high occurrence of solitary pan-
creatic metastases from lung cancer is mainly based on
autopsy reports. These tumors are usually asymptomatic
or present with vague symptoms that can delay the diag-
nosis of metastatic disease. When they become clinically
evident, their most common manifestations are that of
obstructive jaundice and/or acute pancreatitis [2,3]. These
cases, usually involve patients with widespread, dissemi-
nated disease, so therapeutic management is mostly palli-
ative and symptomatic. Nonetheless, there have been a
few scattered reports of radical surgical interventions to
selected patients.
In this report, we present the case of 77-year-old patient
with non-small-cell lung carcinoma who presented with a
metachronous solitary pancreatic metastases that became
clinically evident with recurring episodes of cholangitis
and obstructive jaundice, as well as symptoms of gastric
outlet obstruction.
Case-Presentation
A 77-year-old Caucasian male patient, with a history of
triscupid deficiency, coronary heart disease, arterial hyper-
tension and a permanent pacemaker placement due to
bradyarrythmia was diagnosed with a solitary lesion of
the lower lobe of the left lung on September 2006, an inci-
dental finding in a routine chest x-ray. This finding was
confirmed by a chest CT, which in turn revealed a 2.5 × 2
cm solitary lesion on the lower lobe of the left lung. At
that time, no evidence of metastatic disease was demon-
strated from the patient's additional radiologic examina-
tion. Subsequently, he underwent a lower lobectomy of
the left lung with an uneventful recovery.
Pathological examination confirmed a low-grade squa-
mous carcinoma of the lung, with peripheral spots of ade-
nocarcinoma with clear surgical margins and negative
lymph nodes. Postoperatively the patient received a
regime of adjuvant chemotherapy consisting of 4 cycles of
Paclitaxel (Taxol) and Carboplatin.
For the following 2 years the patient did well without any
evidence of local or systemic recurrence. On November
2008 a routine follow-up chest CT revealed osteolytic
abnormalities of the 5th left rib, consistent with secondary
deposits [Figure 1]. A few days later the patient was admit-
ted to the hospital presenting with high fever (38.5°C),
rigor, recurrent vomiting resulting in incapability to eat,
right upper quadrant pain and jaundice. Radiological
examination of the abdomen with both an ultrasound
and a computed tomography revealed cholelithiasis and a
highly suspicious, well circumscribed lesion of the pancre-
atic head, with both cystic and solid elements, resulting in
distention of both intra- and extra-hepatic biliary tree and
causing pyloric stenosis [Figure 2]. A protruding, distorted
Vater ampulla with adenomatoid appearance, as well as
distention of intra- and extra-hepatic billiary tree, second-
ary to stenosis of the distal common bile duct was
revealed on a subsequent ERCP. Endoscopic sphincterec-
tomy was performed and a plastic stent was placed in the
common bile duct. Fine needle aspiration of the pancre-
atic head lesion under EUS guidance disclosed a low grade
squamous carcinoma with immunohistochemical charac-
teristics consistent with metastatic lung carcinoma [Fig-
CT scan image of the patient's chest showing osteolytic  abnormalities of the 5th left rib, consistent with secondary  deposits Figure 1
CT scan image of the patient's chest showing osteo-
lytic abnormalities of the 5th left rib, consistent with 
secondary deposits.
 
Abdominal CT scan image showing the well circumscribed  lesion of the pancreatic head (the common bile duct stent is  clearly discerned) Figure 2
Abdominal CT scan image showing the well circum-
scribed lesion of the pancreatic head (the common 
bile duct stent is clearly discerned).Cases Journal 2009, 2:9113 http://www.casesjournal.com/content/2/1/9113
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ures 3, 4]. Two months later the patient underwent a
gastrojejunostomy and an open cholecystectomy due to
persistent symptoms of gastric outlet obstruction.
The patient had an uneventful recovery and remained in
good clinical condition for the following three months.
Progressively he developed symptoms of disseminated
disease and finally died five months post-laparotomy.
Discussion
The pancreas is a relatively infrequent site of distant
metastasis. Moreover, metastatic tumors to the pancreas
rarely become clinically evident, although their incidence
has been reported to be approximately 12% in autopsy
reports of patients suffering from other malignancies [4].
The most frequent sources of pancreatic malignant metas-
tases originate from the lung, breast, kidney, gastrointesti-
nal tract, thyroid, melanoma, and liver. Melanomas and
osteosarcomas are also among the tumors that metasta-
size to the pancreas. The route of metastases is lymphatic
(28%), vascular (27%), lymphatic - vascular (19%) and
by direct invasion (18%) [1]. Such lesions usually appear
in patients between 60-70 years of age [5]. The most com-
mon manifestation is that of a solitary mass, located in the
head of the pancreas [5].
Primary lung cancer metastasizes to distant organs quite
frequently. The most common sites of lung cancer metas-
tases are the bones, liver and adrenal glands. The pancreas
is a rather uncommon location of metastatic lung cancer.
Evidence about it is based on scattered case reports in the
literature that usually concern patients at an advanced
stage of their disease, thus eligible only for palliative treat-
ment. It is estimated that the incidence of secondary pan-
creatic deposits resulting from the various types of lung
cancer range from 14.2% - 18. 2% [1,6]. The majority of
these cases arise from small cell lung carcinomas (63%),
and only rarely from adenocarcinoma (11.4%), large cell
carcinoma (5.7%), squamous cell carcinoma (5.7%) and
anaplastic carcinoma (2.9%) [7].
Symptoms caused by metastatic pancreatic lesions are var-
iable and most patients are free of organ - specific com-
plaints. Metastatic disease is usually incidentally detected
on abdominal CT scan during the follow-up period. Those
patients that do have clinical manifestations may present
with abdominal or back pain, nausea, weight loss, jaun-
dice, gastrointestinal haemorrhage or intestinal obstruc-
tion [8]. Moreover, whenever the pancreatic metastatic
lesion directly invades the pancreatic duct epithelium it
may clinically mimic primary pancreatic adenocarcinoma
or, less commonly, induce acute pancreatitis [9-11].
The diagnosis is usually confirmed by percutaneous fine
needle aspiration of the pancreatic lesion under CT guid-
ance or endoscopic ultrasound (EUS) or by cytological
examination of brushing specimens obtained during
endoscopic retrograde cholangiopancreatography
(ERCP)).
Treatment options for metastatic lung cancer lesions to
the pancreas are mainly of palliative intent. They can be
either non-invasive or invasine - surgical. Non-invasive
View of cytological picture, demonstrating abnormal pancre- atic cells, with squamoid features (H & E stain, 2 × 400) Figure 3
View of cytological picture, demonstrating abnormal 
pancreatic cells, with squamoid features (H & E stain, 
2 × 400).
View of cytological picture, demonstrating abnormal epithe- lial cells with subtle tubular arrangement (Pap stain, 4 × 600) Figure 4
View of cytological picture, demonstrating abnormal 
epithelial cells with subtle tubular arrangement (Pap 
stain, 4 × 600).Cases Journal 2009, 2:9113 http://www.casesjournal.com/content/2/1/9113
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treatment options can be chemotherapy and/or common
bile duct stenting, in order to relieve the patient from
jaundice and its symptoms. When surgical treatment is
contemplated this is usually limited to by-pass procedures
in patients with obstructive jaundice. There have been a
few reports of patients who underwent pancreatic resec-
tions for metastatic lung cancer lesions, but this was either
in ignorance of or overseeing the fact that the aetiology of
the obstruction was of metastatic origin [3,12]. There have
been several papers suggesting that pancreatectomy for
metastatic lesions may result in improved survival rates
and disease free intervals [13-15]. However, these results
involve patients with metastatic pancreatic lesions of dif-
ferent histologic origin, such as renal cell cancer, lung,
breast and colonic cancer. Further studies are required in
order to determine whether aggressive surgical treatment
is beneficial in patients with secondary pancreatic depos-
its from lung cancer.
Non-small cell lung cancer with distant metastases (stage
IV) has a poor prognosis. Platinum-based chemotherapy
regimens have been shown to improve survival and
enhance quality of life, and they are also cost effective.
This treatment is most appropriate for patients with a
good performance status. EGFR inhibitors are used as sec-
ond or third line therapy. They are most effective in
women, in patients who have never smoked, or are diag-
nosed with adenocarcinoma. Studies of other novel
agents and non-platinum-based regimens are ongoing.
Median survival has been reported to improve from 3.6 to
approximately 6.5 months after chemotherapy [3]. Resec-
tion of an isolated brain metastasis in patients with a good
performance status has been shown to improve survival.
However, there is very little information about the sur-
vival benefit resulting from resection of solitary metastasis
to the pancreas with curative intent. In a small series by
Hiotis et al of 3 patients with metachronous non-small-
cell cancer pancreatic metastasis who underwent pancrea-
tectomy, all patients were reported to have eventually
developed recurrence [3,15]. Whether all patients who are
at acceptable risk for surgery should be offered pancreatic
resection for isolated mestatatic disease from lung cancer
should be the subject of further future investigations.
Finally, the information above highlights the fact that a
high index of suspicion should be raised for every patient
with a previous history of cancer, who presents with a
pancreatic mass. Therefore, before making any therapeu-
tic decision, any correlation of the pancreatic mass with
the patient's previous cancer history should be thoroughly
examined.
Conclusion
Symptomatic metastatic lesions of the pancreas from
squamous cell carcinoma of the lung are extremely rare.
Typically, the patients remain asymptomatic until their
disease reaches a fairly advanced stage, and therapeutic
options are then limited to palliative measures. FNA of the
suspsicious lession is fundamental in order to achieve dif-
ferential diagnosis from other primary pancreatic tumors.
A high index of suspicion is the only way of early detec-
tion and potentially effective treatment for this rare local-
ization of metastatic squamous lung carcinoma.
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